1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Torre-Cisneros J, San-Juan R, Rosso-Fernández CM, Silva JT, Muñoz-Sanz A, Muñoz P, Miguez E, Martín-Dávila P, López-Ruz MA, Vidal E, Cordero E, Montejo M, Blanes M, Fariñas MC, Herrero JI, Rodrigo J, Aguado JM.

    Tuberculosis Prophylaxis With Levofloxacin in Liver Transplant Patients Is Associated With a High Incidence of Tenosynovitis: Safety Analysis of a Multicenter Randomized Trial

    CLINICAL INFECTIOUS DISEASES . 60(11): 1642-1649. Nº de citas: 36

    [doi:10.1093/cid/civ156]

  • Bañón S, Rosillo M, Gómez A, Pérez-Elias MJ, Moreno S, Casado JL.

    Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients

    Endocrine . 49(2): 528-537. Nº de citas: 16

    [doi:10.1007/s12020-014-0489-2]

  • Rodríguez-Baño J, Cisneros JM, Cobos-Trigueros N, Fresco G, Navarro-San Francisco C, Gudiol C, Horcajada JP, López-Cerero L, Martínez JA, Molina J, Montero M, Paño-Pardo JR, Pascual A, Peña C, Pintado V, Retamar P, Tomás M, Borges-Sa M, Garnacho-Montero J, Bou G.

    Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 33(5): 338-341. Nº de citas: 8

    [doi:10.1016/j.eimc.2014.11.015]

  • Rodríguez-Baño J, Cisneros JM, Cobos-Trigueros N, Fresco G, Navarro-San Francisco C, Gudiol C, Horcajada JP, López-Cerero L, Martínez JA, Molina J, Montero M, Paño-Pardo JR, Pascual A, Peña C, Pintado V, Retamar P, Tomás M, Borges-Sa M, Garnacho-Montero J, Bou G.

    Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 33(5): 337-337. Nº de citas: 18

    [doi:10.1016/j.eimc.2014.11.009]

  • Puig-Asensio M, Ruiz-Camps I, Fernández-Ruiz M, Aguado JM, Muñoz P, Valerio M, Delgado-Iribarren A, Merino P, Bereciartua E, Fortún J, Cuenca-Estrella M, Almirante B, CANDIPOP Project, GEIH-GEMICOMED (SEIMC), and REIPI.

    Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . 21(5): .

    [doi:10.1016/j.cmi.2014.12.027]

  • Monge-Maillo B, López-Vélez R.

    Miltefosine for Visceral and Cutaneous Leishmaniasis: Drug Characteristics and Evidence-Based Treatment Recommendations

    CLINICAL INFECTIOUS DISEASES . 60(9): 1398-1404. Nº de citas: 46

    [doi:10.1093/cid/civ004]

  • Sánchez-Montalvá A, Martínez-Pérez Á, Pérez-Molina JA, González-López JJ, Lopez-Vélez R, Salvador F, Sánchez I, Planes AM, Molina I.

    Clinical and Microbiological Profile of a Retrospective Cohort of Enteric Fever in 2 Spanish Tertiary Hospitals

    Medicine . 94(21): . Nº de citas: 2

    [doi:10.1097/MD.0000000000000791]

  • Serrano-Villar S, Sobrino-Vegas P, Monge S, Dronda F, Hernando A, Montero M, Viciana P, Clotet B, Pineda JA, Del Amo J, Moreno S.

    Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in Spain

    JOURNAL OF VIRAL HEPATITIS . 22(5): 496-503. Nº de citas: 13

    [doi:10.1111/jvh.12353]

  • Bruyand M, Ryom L, Shepherd L, Fatkenheuer G, Grulich A, Reiss P, de Wit S, D Arminio Monforte A, Furrer H, Pradier C, Lundgren J, Sabin C, D:A:D study group.

    Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor-Based Combination Antiretroviral Therapy: The D:A:D Study

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 68(5): 568-577. Nº de citas: 29

    [doi:10.1097/QAI.0000000000000523]

  • HIV-CAUSAL Collaboration, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA.

    Boosted Lopinavir- Versus Boosted Atazanavir-Containing Regimens and Immunologic, Virologic, and Clinical Outcomes: A Prospective Study of HIV-Infected Individuals in High-Income Countries

    CLINICAL INFECTIOUS DISEASES . 60(8): 1262-1268. Nº de citas: 4

    [doi:10.1093/cid/ciu1167]

  • Márquez-Rodas I, Martín González M, Nagore E, Gómez-Fernández C, Avilés-Izquierdo JA, Maldonado-Seral C, Soriano V, Majem-Tarruella M, Palomar V, Maseda R, Martín-Carnicero A, Puertolas T, Godoy E, Cerezuela P, Ochoa de Olza M, Campos B, Perez-Ruiz E, Soria A, Gil-Arnaiz I, Gonzalez-Cao M, Galvez E, Arance A, Belon J, de la Cruz-Merino L, Martín-Algarra S.

    Frequency and Characteristics of Familial Melanoma in Spain: The FAM-GEM-1 Study

    Plos One . 10(4): . Nº de citas: 5

    [doi:10.1371/journal.pone.0124239]

  • Estrada, Vicente, Ignacio Bernardino, Jose, Masia, Mar, Antonio Iribarren, Jose, Ortega, Alejandra, Lozano, Fernando, Miralles, Celia, Olalla, Julian, Santos, Jesus, Perez Elias, Maria Jesus, Domingo, Pere, Fernandez Cruz, Arturo.

    Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain

    HIV CLINICAL TRIALS . 16(2): 57-65. Nº de citas: 16

    [doi:10.1179/1528433614Z.0000000008]

  • Oyanguren B, Esteban L, Guillán M, de Felipe A, Alonso Cánovas A, Navas E, Quereda C, Corral I.

    Central nervous system involvement in adult patients with invasive infection caused by Streptococcus agalactiae

    NEUROLOGIA . 30(3): 158-162. Nº de citas: 8

    [doi:10.1016/j.nrl.2013.12.002]

  • Monge-Maillo B, López-Vélez R, Norman FF, Ferrere-González F, Martínez-Pérez Á, Pérez-Molina JA.

    Screening of Imported Infectious Diseases among Asymptomatic Sub-Saharan African and Latin American Immigrants: A Public Health Challenge

    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE . 92(4): 848-856. Nº de citas: 48

    [doi:10.4269/ajtmh.14-0520]

  • Casado JL, Abad-Fernández M, Moreno S, Pérez-Elías MJ, Moreno A, Bernardino JI, Vallejo A.

    Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients

    HIV MEDICINE . 16(4): 240-248. Nº de citas: 16

    [doi:10.1111/hiv.12206]

  • Berenguer J, Zamora FX, Aldámiz-Echevarría T, Von Wichmann MA, Crespo M, López-Aldeguer J, Carrero A, Montes M, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Barros C, Ortega E, Pulido F, Rubio R, Mallolas J, Tural C, Jusdado JJ, Pérez G, Díez C, Álvarez-Pellicer J, Esteban H, Bellón JM, González-García J.

    Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus

    CLINICAL INFECTIOUS DISEASES . 60(6): 950-958. Nº de citas: 33

    [doi:10.1093/cid/ciu939]

  • Shaw E, Miró JM, Puig-Asensio M, Pigrau C, Barcenilla F, Murillas J, Garcia-Pardo G, Espejo E, Padilla B, Garcia-Reyne A, Pasquau J, Rodriguez-Baño J, López-Contreras J, Montero M, de la Calle C, Pintado V, Calbo E, Gasch O, Montejo M, Salavert M, Garcia-Pais MJ, Carratalà J, Pujol M, Instituto de Salud Carlos III, Madrid, Spain.

    Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial

    BMJ open . 5(3): . Nº de citas: 31

    [doi:10.1136/bmjopen-2014-006723]

  • Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L, D:A:D study group, Royal Free Hospital Clinic Cohort, INSIGHT study group, SMART study group, ESPRIT study group.

    Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLOS MEDICINE . 12(3): . Nº de citas: 99

    [doi:10.1371/journal.pmed.1001809]